vs

Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and Virginia National Bankshares Corp (VABK). Click either name above to swap in a different company.

Virginia National Bankshares Corp is the larger business by last-quarter revenue ($15.0M vs $13.2M, roughly 1.1× TriSalus Life Sciences, Inc.). Virginia National Bankshares Corp runs the higher net margin — 39.7% vs -73.9%, a 113.5% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 3.6%). Virginia National Bankshares Corp produced more free cash flow last quarter ($20.8M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 7.0%).

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

United Bankshares, Inc. is a bank holding company dual-headquartered in Charleston, West Virginia and Fairfax, Virginia with operations in West Virginia, Virginia, the District of Columbia, Maryland, Ohio, Pennsylvania, North Carolina, South Carolina, and Georgia in the United States. United Bankshares is the parent company of United Bank which comprises nearly 250 offices in eight states. In addition, UBSI is the parent company to subsidiaries George Mason Mortgage, United Brokerage, and Cre...

TLSI vs VABK — Head-to-Head

Bigger by revenue
VABK
VABK
1.1× larger
VABK
$15.0M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+56.3% gap
TLSI
59.8%
3.6%
VABK
Higher net margin
VABK
VABK
113.5% more per $
VABK
39.7%
-73.9%
TLSI
More free cash flow
VABK
VABK
$23.3M more FCF
VABK
$20.8M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
7.0%
VABK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TLSI
TLSI
VABK
VABK
Revenue
$13.2M
$15.0M
Net Profit
$-9.8M
$6.0M
Gross Margin
86.7%
Operating Margin
-24.8%
50.5%
Net Margin
-73.9%
39.7%
Revenue YoY
59.8%
3.6%
Net Profit YoY
3.5%
30.6%
EPS (diluted)
$-0.22
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TLSI
TLSI
VABK
VABK
Q4 25
$13.2M
$15.0M
Q3 25
$11.6M
$14.4M
Q2 25
$11.2M
$14.1M
Q1 25
$9.2M
$14.1M
Q4 24
$8.3M
$14.5M
Q3 24
$7.3M
$13.5M
Q2 24
$7.4M
$12.9M
Q1 24
$6.5M
$13.1M
Net Profit
TLSI
TLSI
VABK
VABK
Q4 25
$-9.8M
$6.0M
Q3 25
$-10.8M
$4.6M
Q2 25
$-8.3M
$4.2M
Q1 25
$-10.4M
$4.5M
Q4 24
$-10.1M
$4.6M
Q3 24
$-2.4M
$4.6M
Q2 24
$-4.3M
$4.2M
Q1 24
$-13.2M
$3.6M
Gross Margin
TLSI
TLSI
VABK
VABK
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
TLSI
TLSI
VABK
VABK
Q4 25
-24.8%
50.5%
Q3 25
-77.9%
39.4%
Q2 25
-65.4%
38.4%
Q1 25
-79.9%
38.4%
Q4 24
-91.8%
40.3%
Q3 24
-118.9%
41.9%
Q2 24
-111.0%
39.5%
Q1 24
-180.8%
32.9%
Net Margin
TLSI
TLSI
VABK
VABK
Q4 25
-73.9%
39.7%
Q3 25
-93.5%
31.7%
Q2 25
-73.9%
30.0%
Q1 25
-113.2%
31.9%
Q4 24
-122.4%
31.4%
Q3 24
-32.6%
34.1%
Q2 24
-58.8%
32.3%
Q1 24
-204.5%
27.8%
EPS (diluted)
TLSI
TLSI
VABK
VABK
Q4 25
$-0.22
$1.10
Q3 25
$-0.96
$0.84
Q2 25
$-0.27
$0.78
Q1 25
$-0.39
$0.83
Q4 24
$-0.38
$0.85
Q3 24
$-0.12
$0.85
Q2 24
$-0.21
$0.77
Q1 24
$-0.60
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TLSI
TLSI
VABK
VABK
Cash + ST InvestmentsLiquidity on hand
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-33.9M
$184.2M
Total Assets
$35.3M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TLSI
TLSI
VABK
VABK
Q4 25
$20.4M
Q3 25
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$8.5M
Q3 24
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Stockholders' Equity
TLSI
TLSI
VABK
VABK
Q4 25
$-33.9M
$184.2M
Q3 25
$-26.7M
$177.4M
Q2 25
$-19.4M
$170.8M
Q1 25
$-34.4M
$166.8M
Q4 24
$-25.9M
$160.3M
Q3 24
$-20.4M
$165.9M
Q2 24
$-25.3M
$154.2M
Q1 24
$-36.0M
$152.6M
Total Assets
TLSI
TLSI
VABK
VABK
Q4 25
$35.3M
$1.6B
Q3 25
$36.5M
$1.6B
Q2 25
$41.3M
$1.6B
Q1 25
$28.6M
$1.6B
Q4 24
$24.0M
$1.6B
Q3 24
$27.5M
$1.6B
Q2 24
$32.4M
$1.6B
Q1 24
$17.9M
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TLSI
TLSI
VABK
VABK
Operating Cash FlowLast quarter
$-2.5M
$21.3M
Free Cash FlowOCF − Capex
$-2.5M
$20.8M
FCF MarginFCF / Revenue
-19.1%
138.2%
Capex IntensityCapex / Revenue
0.3%
3.9%
Cash ConversionOCF / Net Profit
3.58×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M
$35.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TLSI
TLSI
VABK
VABK
Q4 25
$-2.5M
$21.3M
Q3 25
$-3.7M
$6.0M
Q2 25
$-7.3M
$6.7M
Q1 25
$-4.5M
$2.1M
Q4 24
$-5.7M
$15.3M
Q3 24
$-10.8M
$15.2M
Q2 24
$-13.4M
$-6.4M
Q1 24
$-10.9M
$3.2M
Free Cash Flow
TLSI
TLSI
VABK
VABK
Q4 25
$-2.5M
$20.8M
Q3 25
$-3.9M
$5.9M
Q2 25
$-7.4M
$6.7M
Q1 25
$-5.3M
$1.8M
Q4 24
$-5.8M
$14.6M
Q3 24
$-11.0M
$15.1M
Q2 24
$-13.5M
$-6.8M
Q1 24
$-10.9M
$3.1M
FCF Margin
TLSI
TLSI
VABK
VABK
Q4 25
-19.1%
138.2%
Q3 25
-33.9%
41.0%
Q2 25
-66.1%
47.6%
Q1 25
-57.3%
13.0%
Q4 24
-69.7%
100.4%
Q3 24
-149.9%
111.7%
Q2 24
-183.1%
-53.0%
Q1 24
-169.3%
23.9%
Capex Intensity
TLSI
TLSI
VABK
VABK
Q4 25
0.3%
3.9%
Q3 25
1.9%
0.5%
Q2 25
0.8%
0.2%
Q1 25
8.2%
1.8%
Q4 24
0.6%
5.1%
Q3 24
2.3%
0.9%
Q2 24
0.8%
3.1%
Q1 24
1.0%
0.2%
Cash Conversion
TLSI
TLSI
VABK
VABK
Q4 25
3.58×
Q3 25
1.31×
Q2 25
1.59×
Q1 25
0.47×
Q4 24
3.35×
Q3 24
3.30×
Q2 24
-1.54×
Q1 24
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons